Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T16:27:31.284Z.
Calculation as of: 2026-10-06T16:27:31.284Z.
Quote observation: 2026-10-06T16:25:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$997.66M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$988.11M
PS Ratio
2.93
TTM Avg
4.81
3Y Avg
13.09
5Y Avg
21.39
Market Cap
$1.02B
PS Ratio
0.98
TTM Avg
1.04
3Y Avg
1.04
5Y Avg
1.04
Market Cap
$1.04B
PS Ratio
0.63
TTM Avg
0.65
3Y Avg
1.07
5Y Avg
1.84
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.00B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $997.66M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $991.32M | 2.49 | 15.04 | 25.67 | 23.89 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $988.11M | 2.93 | 4.81 | 13.09 | 21.39 |
| Aktis Oncology, Inc. (AKTS)vs › | $986.83M | 98.09 | 127.87 | 127.87 | 127.87 |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.56M | 1.32 | 1.39 | 1.65 | 2.62 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 0.98 | 1.04 | 1.04 | 1.04 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 0.63 | 0.65 | 1.07 | 1.84 |
| Immatics N.V. (IMTX)vs › | $1.04B | 21.38 | 20.87 | 13.31 | 11.88 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | 2.91 | 2.52 | 2.44 | 4.32 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
